Drug Profile
SHU 555C
Alternative Names: Ferumoxtran-10 - Bayer Schering Pharma; SH U 555 C; Supravist; Ultrasmall Superparamagnetic Ironoxide; USPIOLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Bayer Schering Pharma
- Class Contrast media; Ferric compounds; Glucans; Oxides
- Mechanism of Action Magnetic resonance imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Ischaemic heart disorders
Most Recent Events
- 13 Jul 2010 No development reported - Preregistration for Ischaemic heart disorders diagnosis in Sweden (IV)
- 21 Oct 2009 Regulatory discussions are ongoing with SHU 555C
- 31 Dec 2006 Preregistration for Ischaemic heart disorders (diagnosis) in Sweden (IV)